SYSTEMS FOR TRANSCATHETER AORTIC VALVE TREATMENT

(19)

(11)

EP 3 288 491 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	16.11.2022 Bulletin 2022/46

(45)	Mention of the grant of the patent:
	26.10.2022 Bulletin 2022/43

(21)	Application number: 16787117.7

(22)	Date of filing: 28.04.2016

(51)

International Patent Classification (IPC):

A61F 2/01^(2006.01)
A61F 2/24^(2006.01)
A61M 25/00^(2006.01)

A61F 2/06^(2013.01)
A61M 1/36^(2006.01)
A61M 29/02^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61F 2/2436; A61F 2002/016; A61F 2230/0067; A61F 2230/0069; A61F 2230/0093; A61M 2025/0681; A61F 2/013

(86)	International application number:
	PCT/US2016/029701

(87)	International publication number:
	WO 2016/176409 (03.11.2016 Gazette 2016/44)

(54)	SYSTEMS FOR TRANSCATHETER AORTIC VALVE TREATMENT SYSTEME ZUR TRANSKATHETER-AORTENKLAPPEN-BEHANDLUNG SYSTÈMES DE TRAITEMENT DE VALVE AORTIQUE TRANS-CATHÉTER

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

30.04.2015 US 201562155384 P
27.08.2015 US 201562210919 P

(43)	Date of publication of application:
	07.03.2018 Bulletin 2018/10

(60)	Divisional application:
	22199265.4

(73)	Proprietor: Silk Road Medical, Inc.
	Sunnyvale, California 94089 (US)

(72)	Inventors:
	ROGERS, Erica J. Sunnyvale, CA 94085 (US) WALLACE, Michael P. Sunnyvale, CA 94085 (US) MACDONALD, Sumaira Sunnyvale, CA 94085 (US) GARRISON, Michi E. Sunnyvale, CA 94085 (US)

(74)	Representative: Slingsby Partners LLP
	1 Kingsway London WC2B 6AN London WC2B 6AN (GB)

(56)

References cited: :

US-A1- 2005 245 892
US-A1- 2011 213 459
US-A1- 2014 031 925

US-A1- 2011 144 690
US-A1- 2013 281 788
US-B1- 6 514 226

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).